Skip Navigation

Details for High Impact Journal

Superfund Research Program

Clinical Cancer Research : An Official Journal of the American Association for Cancer Research (impact factor: 12.531)

2014

  • Karkare S, Chhipa RR, Anderson J, Liu X, Henry HF, Gasilina A, Nassar N, Roychoudhury J, Clark JP, Kumar A, Pauletti GM, Ghosh PK, Dasgupta B. 2014. Direct inhibition of retinoblastoma phosphorylation by nimbolide causes cell-cycle arrest and suppresses glioblastoma growth. Clin Cancer Res 20(1):199-212. doi:10.1158/1078-0432.CCR-13-0762 PMID:24170547 PMCID:PMC3947304

2011

2010

2006

  • Goldberg Z, Rocke DM, Schwietert C, Berglund SR, Santana A, Jones A, Lehmann J, Stern RL, Lu R, Hartmann Siantar CL. 2006. Human in vivo dose response to controlled, low-dose low LET ionizing radiation exposure. Clin Cancer Res 12(12):3723-3729. PMID:16778099

2004

  • Caruso RP, Levinson B, Melamed J, Wieczorek R, Taneja S, Polsky D, Chang C, Zeleniuch-Jacquotte A, Salnikow K, Yee H, Costa M, Osman I. 2004. Altered N-myc downstream-regulated gene 1 protein expression in African-American compared with caucasian prostate cancer patients. Clin Cancer Res 10(1):222-227. PMID:14734473

2001

  • Warren AJ, Mustra DJ, Hamilton JW. 2001. Detection of mitomycin C-DNA adducts in human breast cancer cells grown in culture, as xenografted tumors in nude mice, and in biopsies of human breast cancer patient tumors as determined by (32)P-postlabeling. Clin Cancer Res 7(4):1033-1042. PMID:11309355

1997

  • Ihnat MA, Lariviere JP, Warren AJ, La Ronde N, Blaxall JN, Pierre KM, Turpie BW, Hamilton JW. 1997. Suppression of p-glycoprotein expression and multi-drug resistance by DNA crosslinking agents. Clin Cancer Res 3:1339-1346. PMID:9815817
Back
to Top